Plooster Matthew R 4
4 · KEMPHARM, INC · Filed May 18, 2022
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Plooster Matthew R
Director
Transactions
- Purchase
Common Stock
2022-05-18$4.95/sh+915$4,529→ 4,110 total - Purchase
Common Stock
2022-05-18$4.96/sh+3,051$15,133→ 7,161 total - Purchase
Common Stock
2022-05-18$4.94/sh+695$3,433→ 3,195 total - Purchase
Common Stock
2022-05-18$4.97/sh+339$1,685→ 7,500 total
Holdings
- 69(indirect: By Trust)
Common Stock
- 1,532
Common Stock
Footnotes (1)
- [F1]Held jointly with spouse.